Concepedia

Author

A H Calvert

Newcastle University

Also Known As

A Calvert, A H Calvert, A Hilary Calvert, A N Hughes, A. Calvert, A. H. Calvert, A. Hilary Calvert, A.H Calvert, A.H. Calvert, A.Hilary Calvert

116

Publications

5.3K

Citations

38

H-Index

69

Concepts

All Affiliations

Newcastle UniversityInstitute of Cancer ResearchRoyal Marsden HospitalNorth Tyneside General Hospital
AH

About

A H Calvert is an author at Newcastle University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

43

2.9K

2

Biochemistry

15

16

1.2K

3

Natural Sciences

9

9

662

4

Health Sciences

3

3

241

5

Allergy

1

1

35

A H Calvert

×

64

Publications

4.7K

Citations

36

H-Index

YearCitations

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton,

JNCI Journal of the National Cancer Institute

2004

482

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

Yan Zhao, Huw D. Thomas, Michael A. Batey,

Cancer Research

2006

440

ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

A.L. Jackman, G A Taylor, William Gibson,

PubMed

1991

359

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.

Clet Niyikiza, Sharyn D. Baker, David E. Seitz,

PubMed

2002

247

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

Terence R. Jones, A H Calvert, Ann L. Jackman,

European Journal of Cancer (1965)

1981

239

Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

Laura Biganzoli, Tanja Čufer, P.F. Bruning,

Journal of Clinical Oncology

2002

216

Advanced epithelial ovarian cancer: 1993 consensus statements

Darlene Allen, J. Baak, D Belpomme,

Annals of Oncology

1993

185

Resistance-Modifying Agents. 5. Synthesis and Biological Properties of Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase (PARP)

Roger J. Griffin, Sheila Srinivasan, Karen J. Bowman,

Journal of Medicinal Chemistry

1998

125

Cisplatin/carboplatin cross-resistance in ovarian cancer

ME Gore, I Fryatt, E. Wiltshaw,

British Journal of Cancer

1989

117

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.

B D Evans, K. Srujan Raju, A H Calvert,

PubMed

1983

114

Page 1